Literature DB >> 15149303

Identification of a male schizophrenic patient carrying a de novo balanced translocation, t(4; 13)(p16.1; q21.31).

Masanari Itokawa1, Takehiko Kasuga, Takeo Yoshikawa, Masaaki Matsushita.   

Abstract

Herein is reported the case of a male patient with schizophrenia who displayed a de novo balanced translocation between the short arm of chromosome 4 and the long arm of chromosome 13, t(4; 13)(p16.1; q21.31). The 4p16.1 region is where the causative gene (WFS1) for Wolfram syndrome has been mapped. In Wolfram syndrome, approximately 60% of patients suffer from major mental illness. The other breakpoint, chromosome 13q21.31, is another region where previous linkage studies have repeatedly detected linkage to schizophrenia. The documentation of the present case could therefore provide a valuable resource for identifying disease susceptibility genes by localizing the breakpoints.

Entities:  

Mesh:

Year:  2004        PMID: 15149303     DOI: 10.1111/j.1440-1819.2004.01241.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

Review 1.  Implication of Genes for the N-Methyl-D-Aspartate (NMDA) Receptor in Substance Addictions.

Authors:  Jiali Chen; Yunlong Ma; Rongli Fan; Zhongli Yang; Ming D Li
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

2.  Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder.

Authors:  Sharon L Graw; Karen Swisshelm; Kirsten Floyd; Billie J Carstens; Marianne Z Wamboldt; Randall G Ross; Sherry Leonard
Journal:  Mol Cytogenet       Date:  2012-01-03       Impact factor: 2.009

3.  Aggregation of the protein TRIOBP-1 and its potential relevance to schizophrenia.

Authors:  Nicholas J Bradshaw; Verian Bader; Ingrid Prikulis; Angelika Lueking; Stefan Müllner; Carsten Korth
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

4.  Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia.

Authors:  Tetsuo Ohnishi; Yuji Kiyama; Fumiko Arima-Yoshida; Mitsutaka Kadota; Tomoe Ichikawa; Kazuyuki Yamada; Akiko Watanabe; Hisako Ohba; Kaori Tanaka; Akihiro Nakaya; Yasue Horiuchi; Yoshimi Iwayama; Manabu Toyoshima; Itone Ogawa; Chie Shimamoto-Mitsuyama; Motoko Maekawa; Shabeesh Balan; Makoto Arai; Mitsuhiro Miyashita; Kazuya Toriumi; Yayoi Nozaki; Rumi Kurokawa; Kazuhiro Suzuki; Akane Yoshikawa; Tomoko Toyota; Toshihiko Hosoya; Hiroyuki Okuno; Haruhiko Bito; Masanari Itokawa; Shigehiro Kuraku; Toshiya Manabe; Takeo Yoshikawa
Journal:  EMBO Mol Med       Date:  2021-03-03       Impact factor: 12.137

5.  Behavioral characterization of a novel Cisd2 mutant mouse.

Authors:  Christiann H Gaines; Angela E Snyder; Robin B Ervin; Joseph Farrington; Kenneth Walsh; Sarah A Schoenrock; Lisa M Tarantino
Journal:  Behav Brain Res       Date:  2021-02-18       Impact factor: 3.332

6.  LDB2 locus disruption on 4p16.1 as a risk factor for schizophrenia and bipolar disorder.

Authors:  Yasue Horiuchi; Tomoe Ichikawa; Tetsuo Ohnishi; Yoshimi Iwayama; Kazuya Toriumi; Mitsuhiro Miyashita; Izumi Nohara; Nanako Obata; Tomoko Toyota; Takeo Yoshikawa; Masanari Itokawa; Makoto Arai
Journal:  Hum Genome Var       Date:  2020-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.